Drug firm Dr Reddy's Laboratories today said it has launched Amlodipine Besylate and Benazepril

RELATED ARTICLES Dr Reddy's launches lansoprazole capsules in US market Dr Reddy's, Sun Pharma get USFDA nod for heart disease drug

Hydrochloride capsules, used in treating high blood pressure, in the US market following approval from the US Food and Drug Administration (USFDA).

The company launched the capsules in the US market on July 5 in strengths of 5 mg/40 mg and 10 mg/40 mg, respectively, Dr Reddy's Laboratories said in a statement.

"Dr Reddy's Amlodipine Besylate and Benazepril Hydrochloride capsules in 5 mg/40 mg and 10 mg/40 mg strengths are available in 100-count bottles," it added.

Amlodipine Besylate and Benazepril Hydrochloride capsules are the generic version of Novartis' Lotrel capsules. According to IMS Health sales data, the Lotrel brand had US sales of nearly $290 million for the twelve months ending March, 2011.

Amlodipine Besylate and Benazepril Hydrochloride capsules are indicated for the treatment of hypertension.

Shares of Dr Reddy's Laboratories were being quoted at Rs 1,553.50 apiece on the Bombay Stock Exchange in late afternoon trade today, up 1.67 per cent from their previous close.